Cyclobenzaprine hydrochloride 10 MG Oral Tablet — RxCUI 828348
RxNorm drug concept · Semantic clinical drug
RxCUI 828348
Semantic clinical drug · SCD
● Current RxNorm concept 132 FDA products
556 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI828348
Official nameCyclobenzaprine hydrochloride 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascyclobenzaprine HCl 10 MG Oral Tablet
FDA products mapped132
Package NDCs mapped556
Reported Medicaid activity (SDUD)3,937,876 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cyclobenzaprine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a muscle relaxant prescribed to help ease muscle spasms, pain, and stiffness from acute musculoskeletal injuries — like a back strain or a pulled muscle. It's meant to be used...
- What is cyclobenzaprine actually used for?
- Yes, drowsiness is one of the most common side effects — it's real and can be significant. You should not drive, operate heavy machinery, or do anything that requires sharp focus u...
- Will this make me really drowsy? Can I drive?
🕸️ Concept Web — How Cyclobenzaprine hydrochloride 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cyclobenzaprine hydrochloride 10 MG Oral Tablet
RxCUI 828348 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Cyclobenzaprine
21949IN -
Cyclobenzaprine hydrochloride
52101PIN
-
Cyclobenzaprine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cyclobenzaprine Oral Tablet
371661SCDF -
Cyclobenzaprine hydrochloride Oral Tablet
2646945SCDFP -
Cyclobenzaprine Oral Product
1156628SCDG -
Cyclobenzaprine Pill
1156629SCDG -
Cyclobenzaprine hydrochloride Oral Product
2660158SCDGP -
Cyclobenzaprine hydrochloride Pill
2661873SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Cyclobenzaprine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cyclobenzaprine hydrochloride 10 MG
828347SCDC
-
Cyclobenzaprine hydrochloride 10 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cyclobenzaprine hydrochloride 10 MG
SCDC · 828347 -
Cyclobenzaprine Oral Tablet
SCDF · 371661 -
Cyclobenzaprine hydrochloride Oral Tablet
SCDFP · 2646945 -
Cyclobenzaprine Oral Product
SCDG · 1156628 -
Cyclobenzaprine Pill
SCDG · 1156629 -
Cyclobenzaprine hydrochloride Oral Product
SCDGP · 2660158 -
Cyclobenzaprine hydrochloride Pill
SCDGP · 2661873
📦 FDA Products & Package NDCs
132 products · 556 package NDCs
556 package NDCs map to RxCUI 828348 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72189-0545-90 | 90 TABLET, FILM COATED in 1 BOTTLE (72189-545-90) | Cyclobenzaprine Hydrochloride | Direct_Rx | 2024-04-09 |
| 72189-0680-30 | 30 TABLET, FILM COATED in 1 BOTTLE (72189-680-30) | Cyclobenzaprine HCL | Direct_Rx | 2026-06-29 |
| 72189-0680-60 | 60 TABLET, FILM COATED in 1 BOTTLE (72189-680-60) | Cyclobenzaprine HCL | Direct_Rx | 2026-06-29 |
| 72189-0680-90 | 90 TABLET, FILM COATED in 1 BOTTLE (72189-680-90) | Cyclobenzaprine HCL | Direct_Rx | 2026-06-29 |
| 72603-0310-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72603-310-01) | Cyclobenzaprine Hydrochloride | NORTHSTAR RX LLC | 2024-11-01 |
| 72603-0310-02 | 500 TABLET, FILM COATED in 1 BOTTLE (72603-310-02) | Cyclobenzaprine Hydrochloride | NORTHSTAR RX LLC | 2024-11-01 |
| 72603-0311-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72603-311-01) | Cyclobenzaprine Hydrochloride | NORTHSTAR RX LLC | 2024-11-01 |
| 72603-0312-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72603-312-01) | Cyclobenzaprine Hydrochloride | NORTHSTAR RX LLC | 2024-11-01 |
| 72603-0312-02 | 500 TABLET, FILM COATED in 1 BOTTLE (72603-312-02) | Cyclobenzaprine Hydrochloride | NORTHSTAR RX LLC | 2024-11-01 |
| 72603-0312-03 | 1000 TABLET, FILM COATED in 1 BOTTLE (72603-312-03) | Cyclobenzaprine Hydrochloride | NORTHSTAR RX LLC | 2024-11-01 |
| 72789-0036-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-01) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2019-12-13 |
| 72789-0036-15 | 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-15) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2017-03-30 |
| 72789-0036-21 | 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-21) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2017-03-30 |
| 72789-0036-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-30) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-02-25 |
| 72789-0036-45 | 45 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-45) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-02-25 |
| 72789-0036-60 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-60) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-02-25 |
| 72789-0036-82 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-82) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2019-12-13 |
| 72789-0036-90 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-90) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-02-25 |
| 72789-0036-93 | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-93) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-02-25 |
| 72789-0036-94 | 270 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-94) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-02-25 |
| 72789-0036-95 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-95) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2019-12-13 |
| 72789-0036-98 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-036-98) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-02-25 |
| 72789-0046-03 | 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-03) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-01-07 |
| 72789-0046-04 | 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-04) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-01-06 |
| 72789-0046-06 | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-06) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-07-17 |
| 72789-0046-10 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-10) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-01-08 |
| 72789-0046-12 | 12 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-12) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-06-15 |
| 72789-0046-14 | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-14) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-01-27 |
| 72789-0046-20 | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-20) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-01-06 |
| 72789-0046-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-30) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-01-06 |
| 72789-0046-40 | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-40) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-06-01 |
| 72789-0046-60 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-046-60) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2020-01-06 |
| 72789-0156-15 | 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-156-15) | Cyclobenzaprine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2021-01-12 |
| 72888-0012-00 | 1000 TABLET, FILM COATED in 1 BOTTLE (72888-012-00) | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | 2021-11-01 |
| 72888-0012-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72888-012-01) | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | 2017-05-31 |
| 72888-0012-05 | 500 TABLET, FILM COATED in 1 BOTTLE (72888-012-05) | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | 2017-05-31 |
| 72888-0013-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72888-013-01) | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | 2017-05-31 |
| 72888-0014-00 | 1000 TABLET, FILM COATED in 1 BOTTLE (72888-014-00) | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | 2017-05-31 |
| 72888-0014-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72888-014-01) | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | 2017-05-31 |
| 72888-0014-05 | 500 TABLET, FILM COATED in 1 BOTTLE (72888-014-05) | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | 2017-05-31 |
| 76282-0283-10 | 1000 TABLET in 1 BOTTLE (76282-283-10) | Cyclobenzaprine Hydrochloride | EXELAN PHARMACEUTICALS, INC. | 2025-04-10 |
| 76282-0283-18 | 180 TABLET in 1 BOTTLE (76282-283-18) | Cyclobenzaprine Hydrochloride | EXELAN PHARMACEUTICALS, INC. | 2025-04-10 |
| 76282-0283-27 | 270 TABLET in 1 BOTTLE (76282-283-27) | Cyclobenzaprine Hydrochloride | EXELAN PHARMACEUTICALS, INC. | 2025-04-10 |
| 76282-0283-30 | 30 TABLET in 1 BOTTLE (76282-283-30) | Cyclobenzaprine Hydrochloride | EXELAN PHARMACEUTICALS, INC. | 2025-04-10 |
| 76282-0283-60 | 60 TABLET in 1 BOTTLE (76282-283-60) | Cyclobenzaprine Hydrochloride | EXELAN PHARMACEUTICALS, INC. | 2025-04-10 |
| 76282-0283-90 | 90 TABLET in 1 BOTTLE (76282-283-90) | Cyclobenzaprine Hydrochloride | EXELAN PHARMACEUTICALS, INC. | 2025-04-10 |
| 76420-0011-01 | 1 TABLET, FILM COATED in 1 BOTTLE (76420-011-01) | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 2020-01-23 |
| 76420-0011-02 | 2 TABLET, FILM COATED in 1 BOTTLE (76420-011-02) | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 2020-01-23 |
| 76420-0011-04 | 4 TABLET, FILM COATED in 1 BOTTLE (76420-011-04) | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 2025-04-11 |
| 76420-0011-05 | 5 TABLET, FILM COATED in 1 BOTTLE (76420-011-05) | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 2024-12-24 |
Observed labelers:
Asclemed USA, Inc. (105) ·
Bryant Ranch Prepack (71) ·
Proficient Rx LP (35) ·
A-S Medication Solutions (31) ·
Sportpharm LLC (30) ·
PD-Rx Pharmaceuticals, Inc. (23)
· +38 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.